Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.

Applied Immunohistochemistry & Molecular Morphology : AIMM
James E DavisMeenakshi Singh

Abstract

A subset of patients with ductal carcinoma in situ (DCIS) experience recurrence or progression to invasive cancer. Current clinical practice is not reliably guided by DCIS recurrence prediction, although recurrence risk for invasive breast cancer can now be assessed. We analyzed a panel of biomarkers (estrogen receptor, Her2, Ki67, p53, cyclin D1, COX-2, caveolin-1, survivin, and PPAR-γ) and DCIS histologic and clinical features to determine associations with DCIS recurrence. Seventy DCIS cases diagnosed between 1995 and 2010 were divided into 2 groups: 52 had DCIS without known recurrence after excision and 18 had DCIS with subsequent recurrence after excision as DCIS or invasive carcinoma in the ipsilateral or contralateral breast. Tissue microarrays were prepared, immunohistochemistry performed, and expression of the biomarkers scored semiquantitatively. Variables analyzed included age, tumor size, margin status, DCIS grade, necrosis, histologic type, and immunohistochemistry scores. Differences between groups were evaluated using t tests for continuous variables and Fisher exact tests for categorical variables. Intraductal necrosis was associated with increased recurrence risk: 46% of nonrecurrent cases showed necrosis comp...Continue Reading

References

Jul 23, 1998·Cancer Detection and Prevention·G AlbonicoI Nenci
Dec 14, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·E K LattaF P O'Malley
Nov 13, 2004·Applied Immunohistochemistry & Molecular Morphology : AIMM·Meenakshi SinghKenneth R Shroyer
May 17, 2005·Applied Immunohistochemistry & Molecular Morphology : AIMM·Meenakshi SinghPaul A Seligman
Oct 8, 2005·Advances in Anatomic Pathology·Sharon Nofech-MozesWedad Hanna
Jul 14, 2006·Breast Cancer Research and Treatment·Eileen RakovitchLawrence Paszat
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clive DunneMalcolm R Kell
May 5, 2009·The American Journal of Pathology·Agnieszka K WitkiewiczMichael P Lisanti
Jan 15, 2010·Journal of the National Cancer Institute·Beth A VirnigRobert L Kane
Feb 25, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nigel J BundredJ Michael Dixon
May 10, 2011·Journal of Cancer·Sara A Lari, Henry M Kuerer
Oct 1, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·K HanE Rakovitch
Mar 14, 2012·Advances in Experimental Medicine and Biology·Isabelle Mercier, Michael P Lisanti
Jan 23, 2013·Breast Cancer Research : BCR·Emmi PeuralaArja Jukkola-Vuorinen
May 4, 2013·Journal of the National Cancer Institute·Lawrence J SolinSunil Badve
May 4, 2013·Journal of the National Cancer Institute·Shivani Duggal, Thomas B Julian
Jun 30, 2014·Virchows Archiv : an International Journal of Pathology·Mieke Van BockstalLouis Libbrecht

❮ Previous
Next ❯

Citations

Aug 11, 2016·The Breast : Official Journal of the European Society of Mastology·Angela TossMassimo Cristofanilli
Feb 15, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Wedad M HannaSharon Nofech-Mozes
Sep 9, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Dustin E BoschOliver H Chang
Jun 10, 2020·Tumori·Catherine DeprettoGianfranco P Scaperrotta
May 26, 2017·Oncoscience·R Charles CoombesA Munro Neville
Apr 26, 2019·Veterinary Research Communications·Emerson Soares VelosoEnio Ferreira
Nov 8, 2017·Frontiers in Oncology·Kylie L Gorringe, Stephen B Fox
Nov 18, 2020·British Journal of Cancer·Abeer M ShaabanUNKNOWN Sloane Project Steering Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
A HoqueS M Lippman
© 2021 Meta ULC. All rights reserved